Publications by authors named "A V Kasture"

Background: Balloon-assisted enteroscopy (BAE) (both single- and double-balloon enteroscopy) has garnered attention in the treatment of small intestine strictures in patients with Crohn's disease (CD). This study aimed to evaluate the pooled clinical outcomes of BAE-mediated endoscopic dilation of small intestine strictures in patients with CD.

Methods: We searched multiple databases for articles reporting outcomes following BAE for small intestinal strictures in patients with CD.

View Article and Find Full Text PDF
Article Synopsis
  • Pesticide poisoning, especially from organophosphates, is a significant health issue in India, linked to the agricultural workforce, with a study showing it accounted for 43.56% of 101 poisoning cases.
  • The study, conducted over three months in a tertiary care hospital, collected data on patient demographics, clinical presentation, treatments administered, and outcomes following poisoning incidents.
  • Results highlighted effective management practices, with high rates of proper decontamination (97.02%) and supportive treatment (94.05%), suggesting that timely hospital visits significantly reduce morbidity and mortality.
View Article and Find Full Text PDF

As the first member of the solute carrier 6 (SLC6) protein family, the γ-aminobutyric acid (GABA) transporter 1 (GAT1, ), plays a pivotal role in the uptake of GABA from the synaptic cleft into neurons and astrocytes. This process facilitates the subsequent storage of GABA in presynaptic vesicles. The human gene is highly susceptible to missense mutations, leading to severe clinical outcomes, such as epilepsy, in the afflicted patients.

View Article and Find Full Text PDF

The antidepressants trazodone and nefazodone were approved some 4 and 3 decades ago, respectively. Their action is thought to be mediated, at least in part, by inhibition of the serotonin transporter [SERT/solute carrier (SLC)-6A4]. Surprisingly, their mode of action on SERT has not been characterized.

View Article and Find Full Text PDF

Mutations in the human creatine transporter 1 (CRT1/SLC6A8) cause the creatine transporter deficiency syndrome, which is characterized by intellectual disability, epilepsy, autism, and developmental delay. The vast majority of mutations cause protein misfolding and hence reduce cell surface expression. Hence, it is important to understand the molecular machinery supporting folding and export of CRT1 from the endoplasmic reticulum (ER).

View Article and Find Full Text PDF